AVIVA PLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
AVIVA PLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2020$1,018,000
-56.6%
23,511
-44.8%
0.01%
-64.3%
Q3 2020$2,347,000
+8.3%
42,571
+24.0%
0.01%0.0%
Q2 2020$2,168,000
-40.3%
34,345
-51.6%
0.01%
-48.1%
Q1 2020$3,629,000
+34.3%
71,031
+108.9%
0.03%
+68.8%
Q4 2019$2,703,00034,0030.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders